Subgroups according to BASDAI/ASDAS category (baseline)

Por um escritor misterioso

Descrição

Subgroups according to BASDAI/ASDAS category (baseline)
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Subgroups according to BASDAI/ASDAS category (baseline)
Association between baseline fibromyalgianess severity groupings and
Subgroups according to BASDAI/ASDAS category (baseline)
Monitoring of Disease Activity With a Smartphone App in Routine Clinical Care in Patients With Axial Spondyloarthritis
Subgroups according to BASDAI/ASDAS category (baseline)
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis, Health and Quality of Life Outcomes
Subgroups according to BASDAI/ASDAS category (baseline)
Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central–eastern Europe
Subgroups according to BASDAI/ASDAS category (baseline)
PDF) Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria
Subgroups according to BASDAI/ASDAS category (baseline)
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis, Health and Quality of Life Outcomes
Subgroups according to BASDAI/ASDAS category (baseline)
Extended Report Semantic Scholar
Subgroups according to BASDAI/ASDAS category (baseline)
Baseline values and 3-month response in subgroups according to CRP
Subgroups according to BASDAI/ASDAS category (baseline)
Absolute changes in Bath Ankylosing Spondylitis Disease Activity Index
Subgroups according to BASDAI/ASDAS category (baseline)
Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central–eastern Europe
Subgroups according to BASDAI/ASDAS category (baseline)
Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial - Fabian Proft, Anja Weiß, Murat Torgutalp, Mikhail Protopopov, Valeria Rios Rodriguez, Hildrun
Subgroups according to BASDAI/ASDAS category (baseline)
Subgroups according to BASDAI/ASDAS category (baseline)
de por adulto (o preço varia de acordo com o tamanho do grupo)